Table 2.

Meta-Analysis Results on Motor Function in Patients with SMA Types 2 and 3 Treated with Nusinersen

Instrument		Pooled Mean	95% CI	P
HFMSE	Overall	2.27	1.41–3.13
	Untreated	−1.00	−1.33–0.67
	∆	3.27		<0.0001
RULM	Overall	1.11	0.53–1.69
	Untreated	0.47	−0.79–1.74
	∆			=0.370
6MWT	Overall	19.80 m	6.7–32.89
	Untreated	−8.29 m	−19.10–2.52
	∆			<0.0001

Abbreviation: m, meters.